Clinical Consideration of Obese Infertile Women
![]() |
Nam, Yoon-Sung
(Department of Obstetrics and Gynecology, College of Medicine, Pocheon CHA University)
Jeong, Chang-Jin (Department of Obstetrics and Gynecology, College of Medicine, Pocheon CHA University) Kim, Nam-Keun (Institute for Clinical Research, College of Medicine, Pocheon CHA University) Yoon, Tae-Ki (Department of Obstetrics and Gynecology, College of Medicine, Pocheon CHA University) Cha, Kwang-Yul (Department of Obstetrics and Gynecology, College of Medicine, Pocheon CHA University) |
1 | Dunaif A, Futterweit W, Segal KR, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in the polycystic ovary syndrome. Diabetes 1989; 38: 1165-74 DOI ScienceOn |
2 | Meirow D, Yossepowitch O, Rosler A. Insulin resistant and non-resistant polycystic ovary syndrome present two clinical and endocrinologic subgroups. Hum Reprod 1995; 10: 1951-6 DOI PUBMED |
3 | Flier JS, Eastman RC, Minaker KL, Matteson D, Rowe JW. Acanthosis nigricans in obese women with hyperandrogenism: Characterization of an insulin-resistant state distinct from the type A and B syndromes. Diabetes 1985; 34: 101-7 DOI ScienceOn |
4 | Billar RB, Rishardson D, Schwartz R, Posner B, Little B. Effect of chronically elevated androgen or estrogen on the glucose tolerance test and insulin response in female rhesus monkeys. Am J Obstet Gynecol 1987; 157: 1297-302 DOI |
5 | Nestler JE, Strauss JF. Insulin as an effector of human ovarian and adrenal steroid metabolism. Endocr Metab Clin North Am 1991; 20: 807-23 |
6 | Nestler JE. Sex hormone binding globulin. A marker for hyperinsulinemia and / or insulin resistance? J Clin Endocrinol Metab 1993; 76: 273-4 |
7 | Adashi EY, Hseueh AJW, Yen SCC. Insulin enhancement of luteinizing hormone and follicle stimulating hormone release by cultured pituitary cells. Endocrinology 1981; 108: 1441-9 DOI ScienceOn |
8 | Dunaif A, Scott D, Finegood D, Quintana B, Whit - comb R. The insulin sensitizing agent troglitazone: a novel therapy for the polycystic ovary syndrome. J Clin Endocrinol Metab 1996; 81: 3299-306 DOI |
9 | Halligan A, Bonnar J, Sheppard B. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and preeclamp sia. Br J Obstet Gynecol 1994; 101: 488-92 DOI |
10 | Gris JC, Neveu S, Mares P. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology. J Lab Clin Med 1993; 122: 606-15 |
11 | Nestler JE, Barlascini CO, Matt DW. Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 1989; 68: 1027-32 DOI |
12 | Holmang A, Larsson BM, Brzezinska Z, Bjorntorp P. Effects of short -term testosterone exposure on insulin sensitivity of muscles in female rats. Am J Physiol 1992; 25: 851-5 |
13 | Dunaif A. Insulin resistance and ovarian hyperandrogenism. Endocrinologist 1992; 2: 248-60 DOI |
14 | Barbieri RL, Makris A, Randall RW. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab 1986; 62: 904-10 DOI |
15 | Stuart CA, Prince MJ, Peters EJ, Meyer WJ. Hyperinsulinemia and hyperandrogenemia: in vivo androgen response to insulin infusion. Obstet Gynecol 1987; 69: 921-5 PUBMED |
16 | Clifford K, Rai R, Watson H. Does suppressing luteinizing hormone secretion reduce the miscarriage rate? Results of a randomized controlled trial. BMJ 1996; 312: 1508-11 DOI PUBMED ScienceOn |
17 | Dunaif A, Green G, Futterweit W. Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the PCOS. J Clin Endocrinol Metab 1990; 70: 699-704 DOI |
18 | Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997; 18: 774-800 DOI ScienceOn |
19 | Evans DJ, Hoffman RG, Kalkoff RK, Kissebah AH. Relationship of androgen activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab 1983; 57: 304-10 DOI |
20 | Geffner ME, Kaplan SA, Bersch N, Golde DW, Landaw EM, Chang RJ. Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion. Fertil Steril 1986; 45: 327-33 DOI PUBMED |
21 | Plymate SR, Matej LA, Jones RE, Freidl KE. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab 1988; 67: 460-4 DOI |
22 | Dunaif A, Graf M. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with polycystic ovary syndrome. J Clin Invest 1989; 83: 23-9 DOI ScienceOn |
23 | Estelles A, Grancha S, Gilabert J. Abnormal expression of plasminogen activator inhibitor in patients with gestational trophoblastic disease. Am J Pathol 1996; 149: 1229-39 PUBMED |
24 | Dunaif A. Insulin resistance and ovarian dysfunction. In: Moller DE, editor. Insulin resistance. New York: John Wiley, 1993 |
25 | Gris JC, Ripart -Neveu S, Maugard C. Respective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The Nimes Obstetricians and Haematologists (NOHA) Study. Thromb Haemost 1997; 77: 1096-103 PUBMED |
26 | Kissebah AH, Vydelingum N, Murray R. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982; 54: 254-60 DOI |
27 | Moghetti P, Tosi F, Castello R. The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women. J Clin Endocrinol Metab 1996; 81: 952-60 DOI |
28 | Stuart CA, Nagamani N. Insulin infusion acutely augments ovarian androgen production in normal women. Fertil Steril 1990; 54: 788-92 DOI PUBMED |
29 | Ohlson LO, Larsson B, Svardsudd K. The influence of body fat distribution on the incidence of diabetes mellitus. Diabetes 1985; 34: 1055-8 DOI ScienceOn |
30 |
Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome |
![]() |